Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study
Sponsor: Corsano Health B.V.
Trial Details
| Condition | High Blood Pressure |
| Intervention | Corsano CardioWatch 287-2 non-invasive blood pressure (NIBP) monitoring |
| Phase | NA |
| Status | Completed |
| Participants | 80 |
| Est. Completion | 1 June 2026 |
| Last Updated | 11 June 2026 |
Primary Outcome
Baseline average BP for both CardioWatch 287-2 and reference; Post-treatment average BP for both CardioWatch 287-2 and reference; Average BP change comparing CardioWatch 287-2 and reference
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * aged between 18 and 80 years old; * able to provide consent; * untreated or treated for hypertension, with uncontrolled BP and medical indication for antihypertensive drug initiation or uptitration or change in antihypertensive drug per doctor prescription. Exclusion Criteria: * Unable to wear the Corsano CardioWatch 287 due to reasons such as allergic reactions, wounds, amputations etc.; * Unable to receive blood pressure measurements per cuff due to lymphedema, amputation, dialysis shunt, wounds, etc.; * Pregnant women; * Breastfeeding women; * Upper arm circumference not within the cuff range (22-42 cm) * Unable or not willing to sign for informed consent; * Significant mental or cognitive impairment.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service